<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>MCP-Mod | CSE Tracker</title>
    <link>/tag/20200617mcp-mod/</link>
      <atom:link href="/tag/20200617mcp-mod/index.xml" rel="self" type="application/rss+xml" />
    <description>MCP-Mod</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Wed, 17 Jun 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>MCP-Mod</title>
      <link>/tag/20200617mcp-mod/</link>
    </image>
    
    <item>
      <title>MCP-Mod: Optimizing Phase II Dose Selection for Continuous and Non-Continuous Endpoints</title>
      <link>/webinar/20200617mcp-mod-optimizing-phase-ii-dose-selection-for-continuous-and-non-continuous-endpoints/</link>
      <pubDate>Wed, 17 Jun 2020 00:00:00 +0000</pubDate>
      <guid>/webinar/20200617mcp-mod-optimizing-phase-ii-dose-selection-for-continuous-and-non-continuous-endpoints/</guid>
      <description>&lt;ul&gt;
&lt;li&gt;An introduction to MCP-Mod&lt;/li&gt;
&lt;li&gt;Why use MCP-Mod for Phase II trials&lt;/li&gt;
&lt;li&gt;Steps to generate superior statistical evidence for dose-selection&lt;/li&gt;
&lt;li&gt;MCP-Mod for various endpoints, including: Continuous Endpoint, Binary Endpoint&lt;/li&gt;
&lt;li&gt;Poisson Rates&lt;/li&gt;
&lt;li&gt;Negative Binomial rates&lt;/li&gt;
&lt;li&gt;Worked examples &amp;amp; case studies&lt;/li&gt;
&lt;/ul&gt;</description>
    </item>
    
  </channel>
</rss>
